97759444 - AUGTYROS

Information

• Trademark
• 97759444

• Source

• Serial Number

  97759444

• International Classifications

  • 5 - Pharmaceutical and veterinary preparations

• Filing Date

  January 18, 2023
  a year ago

• Transaction Date

  May 28, 2024
  a month ago

• Status Date

  May 28, 2024
  a month ago

• Published for Opposition Date

  May 28, 2024
  a month ago

• Location Date

  April 25, 2024
  2 months ago

• Status Code

  686

• Current Location

  PUBLICATION AND ISSUE SECTION

  Employee Name

  RAFARI-PEARSON, NIYA M

• Attorney Docket Number

  00161793-US

  Attorney Name

  Marilyn F. Kelly

  Law Office Assigned Location Code

  M30

• Owners

  • TURNING POINT THERAPEUTICS, INC

Case File Statements

• GS0051: Pharmaceutical preparations for human use for the treatment and prevention of obesity, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection, beta thalassemia and myelodysplastic syndromes, myeloproliferative diseases, myelofibrosis, leukemia, lymphoma, multiple myeloma, autoinflammatory disease, blood disease, tumors, multiple sclerosis, ulcerative colitis, arthritis, and musculoskeletal and skin diseases; Pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, pharmaceutical antibodies, immunotherapies for the treatment of cancer, cytokine inhibitory drugs; Pharmaceutical preparations for human use that modulate the immune system; Pharmaceutical and biological preparations for human use for immunotherapy, namely T Cell therapy; Pharmaceutical preparations for human use, namely, stem cells for medical or clinical use; Pharmaceutical preparations for human use for the treatment or prevention of covid-19, coronavirus disease, and respiratory diseases and disorders; Pharmaceutical preparations for human use, namely, antivirals for treatment or prevention of covid-19, coronavirus disease, and respiratory diseases and disorders; Pharmaceutical preparations for human use, namely, monoclonal antibodies for medical use

Case File Event Statements

• 1/21/2023 - a year ago

  1 - NEW APPLICATION ENTERED Type: NWAP

• 1/24/2023 - a year ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 9/23/2023 - 9 months ago

  3 - ASSIGNED TO EXAMINER Type: DOCK

• 9/23/2023 - 9 months ago

  4 - NON-FINAL ACTION WRITTEN Type: CNRT

• 9/23/2023 - 9 months ago

  5 - NON-FINAL ACTION E-MAILED Type: GNRT

• 9/23/2023 - 9 months ago

  6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN

• 12/14/2023 - 6 months ago

  7 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 12/14/2023 - 6 months ago

  8 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 12/15/2023 - 6 months ago

  9 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 4/24/2024 - 2 months ago

  10 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 5/8/2024 - a month ago

  11 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP

• 5/28/2024 - a month ago

  12 - PUBLISHED FOR OPPOSITION Type: PUBO

• 5/28/2024 - a month ago

  13 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB